Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Return on Assets (2018 - 2025)

X4 Pharmaceuticals' Return on Assets history spans 8 years, with the latest figure at 0.35% for Q4 2025.

  • For Q4 2025, Return on Assets fell 12.0% year-over-year to 0.35%; the TTM value through Dec 2025 reached 0.35%, down 12.0%, while the annual FY2025 figure was 0.36%, 11.0% down from the prior year.
  • Return on Assets reached 0.35% in Q4 2025 per XFOR's latest filing, up from 0.71% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.11% in Q2 2024 to a low of 1.04% in Q2 2022.
  • Average Return on Assets over 5 years is 0.59%, with a median of 0.66% recorded in 2023.
  • The largest YoY upside for Return on Assets was 110bps in 2025 against a maximum downside of -98bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.75% in 2021, then rose by 6bps to 0.7% in 2022, then increased by 10bps to 0.63% in 2023, then skyrocketed by 63bps to 0.23% in 2024, then plummeted by -51bps to 0.35% in 2025.
  • Per Business Quant, the three most recent readings for XFOR's Return on Assets are 0.35% (Q4 2025), 0.71% (Q3 2025), and 0.87% (Q2 2025).